ProRx Pharma, the wellness and longevity 503B outsourcing facility, has announced the expansion of its operations to help meet the demand for critical medications—now and into the future with a full health, wellness, and longevity product line.
The company specializes in manufacturing products on the FDA’s drug shortage list, such as semaglutide, offering medications to clinical centers, hospitals and pharmaceutical companies. ProRx is currently expanding its operations to a total of 6,888 square feet, doubling its existing 3,400-square-foot pharmaceutical and manufacturing facility. The new facility with more production space will allow ProRx to triple its manufacturing capabilities and enhance operational processes that will further strengthen compliance with compounding lab Standard Operating Procedures (SOPs) and the FDA. Read More >
